Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R McCurdy

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|February 15, 2021
Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[<i>d</i>]thiazol-2(3<i>H</i>)one σ receptor ligandsSebastiano Intagliata, Hebaalla Agha, Theresa A Kopajtic, et al.
Journal of Medicinal Chemistry|October 1, 2014
Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptorsV Blair Journigan, Christophe Mésangeau, Neha Vyas, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 12, 2018
Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (SN79) DerivativesHilary E Nicholson, Walid F Alsharif, Anthony B Comeau, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2011
N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromersAjay S Yekkirala, Mary M Lunzer, Christopher R McCurdy, et al.
European Journal of Medicinal Chemistry|September 9, 2011
Synthesis and pharmacological evaluation of indole-based sigma receptor ligandsChristophe Mésangeau, Emanuele Amata, Walid Alsharif, et al.
The Journal of Biological Chemistry|May 13, 2017
The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in ratsWeimin Conrad Hong, Hideaki Yano, Takato Hiranita, et al.
The AAPS Journal|December 21, 2011
Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamineMichael J Seminerio, Matthew J Robson, Ahmed H Abdelazeem, et al.
Frontiers in Pharmacology|July 2, 2019
Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced PainThomas J Cirino, Shainnel O Eans, Jessica M Medina, et al.
Substance Use & Misuse|August 25, 2025
Diversification of Kratom in US Markets: Results from an Online Survey and Chemical Assay of ProductsKatherine Hill, Allison Henderson, Abhisheak Sharma, et al.
American Journal of Veterinary Research|December 22, 2025
Diagnostic performance of a human over-the-counter urine test to detect kratom alkaloids and metabolites in canine urineRoman A Mirra, Abigail Ortiz, Michelle Kuntz, et al.
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|February 15, 2021
Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[<i>d</i>]thiazol-2(3<i>H</i>)one σ receptor ligandsSebastiano Intagliata, Hebaalla Agha, Theresa A Kopajtic, et al.
Journal of Medicinal Chemistry|October 1, 2014
Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptorsV Blair Journigan, Christophe Mésangeau, Neha Vyas, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 12, 2018
Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (SN79) DerivativesHilary E Nicholson, Walid F Alsharif, Anthony B Comeau, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2011
N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromersAjay S Yekkirala, Mary M Lunzer, Christopher R McCurdy, et al.
European Journal of Medicinal Chemistry|September 9, 2011
Synthesis and pharmacological evaluation of indole-based sigma receptor ligandsChristophe Mésangeau, Emanuele Amata, Walid Alsharif, et al.
The Journal of Biological Chemistry|May 13, 2017
The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in ratsWeimin Conrad Hong, Hideaki Yano, Takato Hiranita, et al.
The AAPS Journal|December 21, 2011
Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamineMichael J Seminerio, Matthew J Robson, Ahmed H Abdelazeem, et al.
Frontiers in Pharmacology|July 2, 2019
Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced PainThomas J Cirino, Shainnel O Eans, Jessica M Medina, et al.
Substance Use & Misuse|August 25, 2025
Diversification of Kratom in US Markets: Results from an Online Survey and Chemical Assay of ProductsKatherine Hill, Allison Henderson, Abhisheak Sharma, et al.
American Journal of Veterinary Research|December 22, 2025
Diagnostic performance of a human over-the-counter urine test to detect kratom alkaloids and metabolites in canine urineRoman A Mirra, Abigail Ortiz, Michelle Kuntz, et al.
Pageof 22